Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03499067 · ClinicalTrials.gov registry record

A Dispensing Clinical Trial of Test Contact Lens Against Marketed Contact Lens

A clinical trial of Myopia, sponsored by CooperVision.

Completed
Registry status
58
Enrollment target
2
Study locations

NCT03499067: Completed study of Myopia, sponsored by CooperVision.

NCT03499067 is a study of Myopia that has completed, run by CooperVision. The registered enrollment target is 58 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (78% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03499067, a study of Myopia, has completed, sponsored by CooperVision.

COMPLETED
Registry status
58 participants
Enrollment target
2
Study locations

Study Summary

Evaluation of the clinical performance of an investigational silicone-hydrogel contact lens (test) compared to a marketed lens (control), when worn on a daily basis for 1 month.

Primary Outcome

Lens surface wettability was measured on a scale of 0-4, 0.25 steps (0 Very Poor: Immediately displaying non-wetting areas on the lens surface, immediate drying time, 1 Poor: Irregular surface appearance, drying time \<\< blink time, 2 Acceptable: Smooth surface appearance immediately, after the blink becoming irregular after a while, drying time ≤ blink time, 3 Good: Typical soft lens appearance with long drying time 4 Excellent: Appearance of a healthy cornea with very long drying time)

Conditions Studied

Myopia

Interventions

  • DEVICE Test lens
  • DEVICE Control lens

Study Locations (2)

California

  • Clinical Research Center, University of California, Berkeley - Berkeley

Indiana

  • Clinical Optics Research Lab (CORL) Indiana University School of Optometry, Indiana University - Bloomington

Trial Details

FieldValue
Enrollment Target 58 participants
Start Date 2018-04-11
Est. Completion 2018-08-01
CooperVision

64 total trials

What the finished NCT03499067 record still lists

NCT03499067 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 58 participants, a relatively small participant target, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (78% lower).

The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which Test lens is the first listed.

NCT03499067 reports a single indexed study location in California, Indiana.

Frequently Asked Questions

What is clinical trial NCT03499067 about?

NCT03499067 is a clinical study titled "A Dispensing Clinical Trial of Test Contact Lens Against Marketed Contact Lens". Evaluation of the clinical performance of an investigational silicone-hydrogel contact lens (test) compared to a marketed lens (control), when worn on a daily basis for 1 month.

What is the current status of trial NCT03499067?

This trial is currently completed. The enrollment target is 58 participants. The study started on 2018-04-11. Estimated completion is 2018-08-01.

What conditions does trial NCT03499067 study?

This clinical trial studies the following conditions: Myopia.

What interventions are being tested in trial NCT03499067?

The interventions under investigation include: Test lens (DEVICE), Control lens (DEVICE).

Who is sponsoring clinical trial NCT03499067?

This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03499067 being conducted?

This trial has 2 study locations across California, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Myopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03499067's enrollment target sits among peer trials

58 61st of 90 higher than 30 of 90 other Myopia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Myopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03587844 · 58 participants · Phase 2

    Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients

  • NCT03630991 · 58 participants · Phase 1

    Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy

  • NCT03949855 · 58 participants · Phase 2

    Belimumab With Rituximab for Primary Membranous Nephropathy

  • NCT04069273 · 58 participants · Phase 2

    Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT03499067, the US trial registry maintained by the National Library of Medicine. NCT03499067 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.